Dexcom, the local maker of continuous glucose monitors, received a warning letter from the Food and Drug Administration last ...
Dexcom announced today that it received a warning letter from the FDA following inspections of two company facilities.
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz.
DexCom received a warning letter from the Food and Drug Administration following inspections of two of its plants. The maker ...
In a regulatory filing, DexCom (DXCM) disclosed that on March 4, the company received a warning letter from the U.S. FDA following inspections ...
Cheng Xin / Getty Images DexCom received a warning letter from the Food and Drug Administration following inspections of two of its plants. The maker of glucose monitoring devices said ...
Dexcom received a warning letter on March 4 after the Food and Drug Administration found problems at facilities in Arizona and California, the company revealed Friday in a securities filing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results